Gene Therapy: Frees 9 Out of 10 Thalassemia Patients From Transfusions - Not yet Accessible in Greece

Protothema

Right

Factuality

Ownership

Two Greek patients remain transfusion-free eight years after treatment – Cost reaches 2.2 million euros per patient

Iatropedia

Factuality

Ownership

Gene therapy for hemoglobinopathies, such as thalassemia and sickle cell disease, has been a scientific reality for about a decade.…

ekriti

Factuality

Ownership

Gene therapy for hemoglobinopathies, i.e. hereditary hemoglobin diseases, such as thalassemia and sickle cell disease, has been a scientific reality for about a decade, with clinical studies showing high rates of effectiveness. There are already approved gene therapy products, however, patients in Greece still do not have access to them. The above is pointed out by hematologist Evangelia Giannaki, director of the Clinical Hematology - Hematopoie…

Capital.gr

Factuality

Ownership

Clinical studies have shown high rates of effectiveness.